Simple Knee Value, a Simple Score for Functional Assessment of the Knee
SKV
1 other identifier
observational
150
1 country
1
Brief Summary
The pre- and post-operative functional assessment of patients' knees is of great interest for the practitioner, whether it is in his or her daily practice to determine the appropriate management of the patient, or to conduct clinical studies. The scores used are established in several languages to provide a uniformly accepted unit of measurement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
December 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJanuary 4, 2023
January 1, 2023
1.8 years
November 3, 2020
January 2, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
SKV and score
The analysis of the correlations between the SKV and the validated Functional Scores is based on the calculation of Spearman correlation coefficients.
Base line
SKV and score
The analysis of the correlations between the SKV and the validated Functional Scores is based on the calculation of Spearman correlation coefficients.
2 weeks
SKV and score
The analysis of the correlations between the SKV and the validated Functional Scores is based on the calculation of Spearman correlation coefficients.
2 months
SKV and score
The analysis of the correlations between the SKV and the validated Functional Scores is based on the calculation of Spearman correlation coefficients.
6 months
Secondary Outcomes (7)
SKV reproducibility
Base line
SKV reproducibility
6 months
SKV sensitivity
Base line
SKV sensitivity
6 months
SKV quality
base line
- +2 more secondary outcomes
Study Arms (2)
Experimental
* Patients aged 16 to 40 years with ACL anterior cruciate ligament rupture, meniscal injury, patella instability or dislocation (Young Adult group), * Patients over 55 years of age with gonarthrosis ("Senior" adults group).
Control
* a group of "young" (16 to 40 years old) * "senior" (over 55 years old) adult controls * Everybody free of knee pathology.
Interventions
Patients will be evaluated identically to routine care with reference tests (Lysholm-Tegner, and Knee injury and Osteoarthritis Outcome Score (KOSS) and, IKDC (Evaluation of knee ligament injuries). This is filled in without any external help. The questionnaire includes the Lysholm-Tegner (young adult group), IKDC and KOOS scores (young and senior adult groups).
Eligibility Criteria
Patients aged 16 to 40 years with ligament rupture anterior cruciate ACL, meniscal lesion, instability or anterior patella dislocation ("young" adult group), and patients over 55 years of age with gonarthrosis. ("Senior" adults group).
You may qualify if:
- For the patients:
- Patients aged 16 to 40 years with ligament rupture anterior cruciate ACL, meniscal lesion, instability or anterior patella dislocation ("young" adult group),
- Patients over 55 years of age with gonarthrosis. ("Senior" adults group).
- For the controls:
- In order to test the discriminating qualities of the SKV score, a group young" (16 to 40 years old) and "senior" (16 to 40 years old) adult witnesses, and 55 years old) with no problems with one of their knees.
- For all participants :
- Understanding French
- Having given its non-opposition and for minors having obtained the non-opposition of one of the holders of parental authority
- Affiliation to a social security scheme
You may not qualify if:
- For all participants :
- Memory disorders,
- Psychiatric disorders,
- Patient refusal to participate in the study,
- Patient under the protection of adults (guardianship, guardianship, safeguarding of justice),
- Pregnant and/or breastfeeding woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etienne Cavaignac
Toulouse, 31000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Etienne CAVAIGNAC, MD
University Hospital, Toulouse
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2020
First Posted
December 4, 2020
Study Start
April 1, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
January 4, 2023
Record last verified: 2023-01